Over the past decade, we have built a portfolio of companies that address today’s growth markets and what we believe could be tomorrow’s growth opportunities. Many of these companies have applications across multiple industry sectors.
ABS Materials (ABS) offers a line of molecularly engineered organosilica products for water purification, advanced separation, and active ingredient delivery.
Accelerator Corporation's New York City enterprise is leveraging the local biotech research centers and universities to successfully invest in and develop early-stage life science technology.
ADESTO TECHNOLOGIES CORPORATION
Adesto is a ‘fabless’ semiconductor memory company that is developing scalable, ultra-fast, low-power, non-volatile memory (NVM) solutions.
Agbiome is a provider of early stage research and discovery for agriculture, exploring the crop microbiome to identify products that reduce risk and improve yield.
AgTech Accelerator is a unique startup accelerator vehicle dedicated to emerging agricultural technologies. It will create the next generation of companies embracing the shift toward collaboration and external innovation in agribusiness today.
ANCORA PHARMACEUTICALS INC.
Ancora Pharmaceuticals develops novel vaccines using synthetic carbohydrates. The majority of Ancora's assets were acquired by CordenPharma in 2013. The remaining portion of the assets are held as SynGlyco, Inc.
Xenio (ZEN-ee-oh) provides commercial IoT solutions by spanning technology embedded in LED light fixtures, site-management software tools, mobile apps and the cloud.
CHAMPIONS ONCOLOGY, INC.
Champions Oncology uses its proprietary TumorGraftTM platform to personalize the development and use of oncology drugs.
D-WAVE SYSTEMS, INC.
D-Wave Systems develops an adiabatic quantum computer (QC).
EchoPixel is shifting the paradigm in the areas of diagnostics, surgical planning, and treatment through its True 3D platform.
ENSEMBLE THERAPEUTICS CORPORATION
Ensemble Therapeutics uses DNA-Programmed Chemistry (DPCTM) to develop small-molecule macrocycle drugs to target protein-protein interactions for the treatment conditions such as inflammation, cancer and diabetes.
ENUMERAL BIOMEDICAL HOLDINGS, INC. (OTC:ENUM)
Enumeral uses its proprietary quantitative immunology platform to discover native human monoclonal antibodies for use in the diagnosis and treatment of infectious, autoimmune and inflammatory diseases.
HZO is a technology solutions company that works directly with OEMs and manufacturers to keep electronics safe after exposure to corrosive environments, water and other liquids, including full submersion.
Interome (Integrated –omics for me) is a seed-stage company focused on discovering a way to bring multiple types of genotypics, phenotypic and physiological information together on a platform that can be used to inform both consumers and medical clinicians.
MERSANA THERAPEUTICS, INC.
Mersana develops novel drug conjugates that aim to maximize the potential of new and established therapeutic classes.
Metabolon, Inc. is the world’s leading health technology company focused on metabolomics – an integrative, powerful tool for assessing health.
MUSES LABS, INC.
Muses Labs has developed a technology platform to enable Precision Medicine in the clinic. Initial solutions focus on cognitive decline and Alzheimer’s disease.
NANO TERRA, INC.
Nano Terra is a nano- and micro-technology development company that develops long-term collaborations with its customers to build significant new business value by applying its interdisciplinary expertise, nano- and micro-technology toolset and knowhow to commercial problems.
Nanosys uses its proprietary zero and one-dimensional nanocrystals to address needs in the display and energy storage markets.
NGXBio creates a tightly integrated platform of technology, partnerships, and logistics to deliver a complete solution -- faster, cheaper, and with responsive customer service.
OPGEN, INC. (NASDAQ: OPGN)
OpGen is developing and selling tools for whole genome mapping for sequence assembly and finishing, and structural variation.
ORIG3N has established the world's largest, uniformly consented cell repository to better understand the cellular and molecular foundations of disease. The cells are ever-renewing and give rise to a living database of humanity they call LifeCapsule
Phylagen is improving human health and productivity by understanding the complete picture of life around us.
PRODUCED WATER ABSORBENTS, INC.
PWAbsorbents (Operating as ProSep, Inc.) is an industry-leading technology and services provider of choice for integrated process solutions to the global oil and gas industry.
Promuc is developing synthetic mucin derivatives for commercial applications in food, beverage, nutrition, skin care, hygiene, and infectious diseases.
SENOVA SYSTEMS, INC.
Senova Systems develops next generation sensors to measure pH, the measure of acidity and basicity of a solution, which is a fundamental property of nature.
TARA Biosystems, Inc.
TARA Biosystems is revolutionizing "human-on-a-chip" technology through its Biowire platform that offers physiologically relevant cardiac models.